Rodrigo L. Hepatitis B 2022

Textbook in PDF format

This book reviews the mechanisms and pathogenesis of hepatitis B virus (HBV), as well as discusses current and potential future treatments.
Current pharmacologic therapies for chronic hepatitis B virus (HBV) infection allow viral suppression and normalization of the liver enzyme alanine aminotransferase (ALT) and prevent liver disease from progressing. The currently available antiviral therapies very rarely lead to a functional cure. Thus, the future of a cure for HBV lies in triple combination therapies with concerted action on replication inhibition, antigen reduction, and immune stimulation.
Epidemiology of Hepatitis B Virus
Hepatitis B Virus, Genotypes and Subtypes
Establishment of a Mouse Model of Chronic Hepatitis B Virus Infection and Purification of Hepatic Parenchymal and Non-Parenchymal Cells
Level of Antibody Response against Hepatitis B Virus after Vaccination and Seroprevalence of HBV in Children Addis Ababa, Ethiopia
Novel Diagnostic Approach and Safe Blood Transfusion Practices for Thalassemia: A Vital Role of a Blood Centre in Western India
Maternal Hepatitis Infections: Determining Seroprevalence of Hepatitis B and C Virus Infections and Associated Risk Factors among Healthy Mothers in Addis Ababa, Ethiopia